☰

Antonis Kirmizis - Publications

Affiliations: 
2004 University of Wisconsin, Madison, Madison, WI 
Tree Info Similar researchers PubMed Report error

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Charidemou E, Noberini R, Ghirardi C, Georgiou P, Marcou P, Theophanous A, Strati K, Keun H, Behrends V, Bonaldi T, Kirmizis A. Hyperacetylated histone H4 is a source of carbon contributing to lipid synthesis. The Embo Journal. PMID 38383863 DOI: 10.1038/s44318-024-00053-0  0.461
2023 Constantinou M, Klavaris A, Koufaris C, Kirmizis A. Cellular effects of NAT-mediated histone N-terminal acetylation. Journal of Cell Science. 136. PMID 37013828 DOI: 10.1242/jcs.260801  0.777
2023 Charidemou E, Koufaris C, Louca M, Kirmizis A, Rubio-Tomás T. Histone methylation in pre-cancerous liver diseases and hepatocellular carcinoma: recent overview. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. PMID 36650321 DOI: 10.1007/s12094-023-03078-9  0.331
2022 Charidemou E, Tsiarli MA, Theophanous A, Yilmaz V, Pitsouli C, Strati K, Griffin JL, Kirmizis A. Histone acetyltransferase NAA40 modulates acetyl-CoA levels and lipid synthesis. Bmc Biology. 20: 22. PMID 35057804 DOI: 10.1186/s12915-021-01225-8  0.597
2021 Demetriadou C, Raoukka A, Charidemou E, Mylonas C, Michael C, Parekh S, Koufaris C, Skourides P, Papageorgis P, Tessarz P, Kirmizis A. Histone N-terminal acetyltransferase NAA40 links one-carbon metabolism to chemoresistance. Oncogene. PMID 34785778 DOI: 10.1038/s41388-021-02113-9  0.843
2021 Koufaris C, Kirmizis A. Identification of NAA40 as a Potential Prognostic Marker for Aggressive Liver Cancer Subtypes. Frontiers in Oncology. 11: 691950. PMID 34150665 DOI: 10.3389/fonc.2021.691950  0.308
2020 Koufaris C, Kirmizis A. N-Terminal Acetyltransferases Are Cancer-Essential Genes Prevalently Upregulated in Tumours. Cancers. 12. PMID 32942614 DOI: 10.3390/Cancers12092631  0.478
2020 Bheda P, Kirmizis A, Schneider R. The past determines the future: sugar source history and transcriptional memory. Current Genetics. PMID 32686056 DOI: 10.1007/S00294-020-01094-8  0.339
2020 Demetriadou C, Koufaris C, Kirmizis A. Histone N-alpha terminal modifications: genome regulation at the tip of the tail. Epigenetics & Chromatin. 13: 29. PMID 32680559 DOI: 10.1186/S13072-020-00352-W  0.858
2020 Kyriakou D, Constantinou M, Kirmizis A. Synthetic dosage lethal (SDL) interaction data of Hmt1 arginine methyltransferase. Data in Brief. 31: 105885. PMID 32637492 DOI: 10.1016/J.Dib.2020.105885  0.731
2020 Bheda P, Aguilar-Gómez D, Becker NB, Becker J, Stavrou E, Kukhtevich I, Höfer T, Maerkl S, Charvin G, Marr C, Kirmizis A, Schneider R. Single-Cell Tracing Dissects Regulation of Maintenance and Inheritance of Transcriptional Reinduction Memory. Molecular Cell. PMID 32392469 DOI: 10.1016/J.Molcel.2020.04.016  0.321
2019 Molina-Serrano D, Kyriakou D, Kirmizis A. Histone Modifications as an Intersection Between Diet and Longevity. Frontiers in Genetics. 10: 192. PMID 30915107 DOI: 10.3389/Fgene.2019.00192  0.831
2019 Demetriadou C, Pavlou D, Mpekris F, Achilleos C, Stylianopoulos T, Zaravinos A, Papageorgis P, Kirmizis A. NAA40 contributes to colorectal cancer growth by controlling PRMT5 expression. Cell Death & Disease. 10: 236. PMID 30858358 DOI: 10.1038/S41419-019-1487-3  0.77
2017 Demetriadou C, Kirmizis A. Histone Acetyltransferases in Cancer: Guardians or Hazards? Critical Reviews in Oncogenesis. 22: 195-218. PMID 29604899 DOI: 10.1615/Critrevoncog.2017024506  0.847
2017 Molina-Serrano D, Kirmizis A. Calorie restriction breaks an epigenetic barrier to longevity. Cell Cycle (Georgetown, Tex.). 0. PMID 28319441 DOI: 10.1080/15384101.2017.1304745  0.666
2016 Kyriakou D, Stavrou E, Demosthenous P, Angelidou G, San Luis BJ, Boone C, Promponas VJ, Kirmizis A. Functional characterisation of long intergenic non-coding RNAs through genetic interaction profiling in Saccharomyces cerevisiae. Bmc Biology. 14: 106. PMID 27927215 DOI: 10.1186/S12915-016-0325-7  0.748
2016 Molina-Serrano D, Schiza V, Demosthenous C, Stavrou E, Oppelt J, Kyriakou D, Liu W, Zisser G, Bergler H, Dang W, Kirmizis A. Loss of Nat4 and its associated histone H4 N-terminal acetylation mediates calorie restriction-induced longevity. Embo Reports. PMID 27799288 DOI: 10.15252/Embr.201642540  0.779
2015 Pavlou D, Kirmizis A. Depletion of histone N-terminal-acetyltransferase Naa40 induces p53-independent apoptosis in colorectal cancer cells via the mitochondrial pathway. Apoptosis : An International Journal On Programmed Cell Death. PMID 26666750 DOI: 10.1007/S10495-015-1207-0  0.777
2013 Schiza V, Molina-Serrano D, Kyriakou D, Hadjiantoniou A, Kirmizis A. N-alpha-terminal acetylation of histone H4 regulates arginine methylation and ribosomal DNA silencing. Plos Genetics. 9: e1003805. PMID 24068969 DOI: 10.1371/Journal.Pgen.1003805  0.803
2013 Molina-Serrano D, Kirmizis A. Beyond the histone tail: acetylation at the nucleosome dyad commands transcription. Nucleus (Austin, Tex.). 4: 343-8. PMID 23941995 DOI: 10.4161/Nucl.26051  0.631
2013 Molina-Serrano D, Schiza V, Kirmizis A. Cross-talk among epigenetic modifications: lessons from histone arginine methylation. Biochemical Society Transactions. 41: 751-9. PMID 23697934 DOI: 10.1042/Bst20130003  0.829
2009 Kirmizis A, Santos-Rosa H, Penkett CJ, Singer MA, Green RD, Kouzarides T. Distinct transcriptional outputs associated with mono- and dimethylated histone H3 arginine 2. Nature Structural & Molecular Biology. 16: 449-51. PMID 19270702 DOI: 10.1038/Nsmb.1569  0.749
2009 Santos-Rosa H, Kirmizis A, Nelson C, Bartke T, Saksouk N, Cote J, Kouzarides T. Histone H3 tail clipping regulates gene expression. Nature Structural & Molecular Biology. 16: 17-22. PMID 19079264 DOI: 10.1038/Nsmb.1534  0.727
2007 Kirmizis A, Santos-Rosa H, Penkett CJ, Singer MA, Vermeulen M, Mann M, Bähler J, Green RD, Kouzarides T. Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation. Nature. 449: 928-32. PMID 17898715 DOI: 10.1038/Nature06160  0.753
2007 de la Cruz CC, Kirmizis A, Simon MD, Isono K, Koseki H, Panning B. The polycomb group protein SUZ12 regulates histone H3 lysine 9 methylation and HP1 alpha distribution. Chromosome Research : An International Journal On the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology. 15: 299-314. PMID 17406994 DOI: 10.1007/S10577-007-1126-1  0.59
2005 Kuzmichev A, Margueron R, Vaquero A, Preissner TS, Scher M, Kirmizis A, Ouyang X, Brockdorff N, Abate-Shen C, Farnham P, Reinberg D. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proceedings of the National Academy of Sciences of the United States of America. 102: 1859-64. PMID 15684044 DOI: 10.1073/Pnas.0409875102  0.748
2004 Reinberg D, Chuikov S, Farnham P, Karachentsev D, Kirmizis A, Kuzmichev A, Margueron R, Nishioka K, Preissner TS, Sarma K, Abate-Shen C, Steward R, Vaquero A. Steps toward understanding the inheritance of repressive methyl-lysine marks in histones. Cold Spring Harbor Symposia On Quantitative Biology. 69: 171-82. PMID 16117647 DOI: 10.1101/Sqb.2004.69.171  0.714
2004 Kirmizis A, Farnham PJ. Genomic approaches that aid in the identification of transcription factor target genes. Experimental Biology and Medicine (Maywood, N.J.). 229: 705-21. PMID 15337825 DOI: 10.1177/153537020422900803  0.664
2004 Kirmizis A, Bartley SM, Kuzmichev A, Margueron R, Reinberg D, Green R, Farnham PJ. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes & Development. 18: 1592-605. PMID 15231737 DOI: 10.1101/Gad.1200204  0.733
2003 Kirmizis A, Bartley SM, Farnham PJ. Identification of the polycomb group protein SU(Z)12 as a potential molecular target for human cancer therapy. Molecular Cancer Therapeutics. 2: 113-21. PMID 12533679  0.628
2001 Farnham P, Graveel C, Kirmizis A, Bartley S, Kel A, Kel-Margoulis O, Wingender E, Zhang M, Jatkoe T, Madore S. Use of chromatin immunoprecipitation to study transcriptional deregulation in cancer cells Nature Genetics. 27: 53-53. DOI: 10.1038/87076  0.809
Show low-probability matches.